澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

NOXOPHARM LTD

0.070

+0.01118.64%

成交量：22.96万

成交额：1.42万

市值：2,045.67万

市盈率：-4.19

高：0.070

开：0.060

低：0.059

收：0.059

52周最高：0.135

52周最低：0.043

股本：2.92亿

流通股本：1.96亿

量比：0.41

换手率：0.12%

股息：- -

股息率：- -

每股收益(TTM):-0.017

每股收益(LYR):-0.017

净资产收益率：-157.93%

总资产收益率：-59.24%

市净率：29.65

市盈率(LYR):-4.19

数据加载中...

总览公司新闻资讯公告

概念

新冠治疗股+0.76%

医药生物股+1.74%

资金流向

资金流入：

资金流出：

新闻资讯

单月暴涨超140%！Noxopharm (ASX:NOX) 红斑狼疮候选药SOF-SKN临试即将推进第二队列

澳洲财经见闻

快讯-澳大利亚Noxopharm启动自体免疫药物试验股价飙升

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NOX.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NOX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","market":"AU","secType":"STK","nameCN":"NOXOPHARM LTD","latestPrice":0.07,"timestamp":1770700320000,"preClose":0.059,"halted":0,"volume":229594,"delay":0,"changeRate":0.18644067796610186,"nameEN":"NOXOPHARM LTD","floatShares":195506720,"shares":292237950,"eps":-0.016712,"marketStatus":"已收盘","change":0.011,"latestTime":"02-10 16:12:00 AEDT","open":0.06,"high":0.07,"low":0.059,"amount":14240,"amplitude":0.186441,"askPrice":0.07,"askSize":69211,"bidPrice":0.058,"bidSize":40000,"shortable":3,"etf":0,"ttmEps":-0.016712,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.059,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.409147,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NOX.AU\",,,,,undefined,":{"symbol":"NOX.AU","floatShares":195506720,"roa":"-59.24%","roe":"-157.93%","lyrEps":-0.016712,"volumeRatio":0.409147,"shares":292237950,"dividePrice":0,"high":0.07,"amplitude":0.186441,"preClose":0.059,"low":0.059,"week52Low":0.043,"pbRate":"29.65","psRate":"7.25","week52High":0.135,"institutionHeld":0,"latestPrice":0.07,"committee":-0.267473,"eps":-0.016712,"divideRate":0,"volume":229594,"delay":0,"ttmEps":-0.016712,"open":0.06,"prevYearClose":0.093,"prevWeekClose":0.059,"prevMonthClose":0.077,"prevQuarterClose":0.093,"fiveDayClose":0.071,"twentyDayClose":0.092,"sixtyDayClose":0.095,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NOX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NOX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NOX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555573833","title":"单月暴涨超140%！Noxopharm (ASX:NOX) 红斑狼疮候选药SOF-SKN临试即将推进第二队列","url":"https://stock-news.laohu8.com/highlight/detail?id=2555573833","media":"澳洲财经见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555573833?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 20:35","pubTimestamp":1753965300,"startTime":"0","endTime":"0","summary":"临床阶段生物科技公司 Noxopharm Ltd (ASX股票代码:NOX) 股价连日异动，周二早盘再度飙涨39%，触及…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/%e5%8d%95%e6%9c%88%e6%9a%b4%e6%b6%a8%e8%b6%85140%ef%bc%81noxopharm-asxnox-%e7%ba%a2%e6%96%91%e7%8b%bc%e7%96%ae%e5%80%99%e9%80%89%e8%8d%afsof-skn%e4%b8%b4%e8%af%95%e5%8d%b3%e5%b0%86%e6%8e%a8/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","NOX.AU","SOF","BK7501","BK7067"],"gpt_icon":0},{"id":"1155127986","title":"快讯-澳大利亚Noxopharm启动自体免疫药物试验 股价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=1155127986","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155127986?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:46","pubTimestamp":1752637570,"startTime":"0","endTime":"0","summary":"澳大利亚生物科技企业Noxopharm(NOX.AX)股价单日暴涨近46%至0.07澳元，创下去年10月4日以来最大单日涨幅。盘中股价触及6月6日以来最高点，此前该公司宣布自体免疫疾病候选药物SOF-SKN完成首例受试者给药。\n市场交投热度骤增，当日成交量达422,086股，达到30日平均交易量的2.2倍。值得关注的是，尽管今日股价强势反弹，该股年内累计跌幅仍达24.7%。\nSOF-SKN作为治疗自体免疫疾病的创新药物，其临床试验进展引发市场强烈反应。投资者密切关注该药物后续研发进程，这将成为影响企业估值走势的关键变量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7508","NOX.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NOX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治疗股","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":0.007617},{"market":"AU","name":"医药生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.017447}]}}